Literature DB >> 31023623

Therapeutic plasma exchange: Review of current indications.

Miguel Fernández-Zarzoso1, Inés Gómez-Seguí2, Javier de la Rubia3.   

Abstract

Therapeutic plasma exchange (TPE) is the extracorporeal technique performed in an apheresis device were patient's plasma is separated from whole blood and removed, while the cellular blood components are returned to the patient together with a replacement fluid. By the extracorporeal removal of pathological substances and the replacement of deficient plasma components, it constitutes an important tool for the management of several disorders and it is a well-known and established treatment for numerous diseases. Additionally, overall available data confirm the safety and efficacy of TPE. Nevertheless, the quality of the evidence supporting the utility and efficacy of the procedure is diverse. This review attempts to compile the current indications of TPE in different disorders according to an extensive and updated literature review, with special focus on its present role and its validity in the twenty-first century medicine.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Guidelines; Indications; Review; Therapeutic plasma exchange

Year:  2019        PMID: 31023623     DOI: 10.1016/j.transci.2019.04.007

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  11 in total

1.  A New Trial to Measure ABO Antibodies Using Complement-Dependent Cytotoxicity.

Authors:  Hee-Jeong Youk; Ho-Yoon Ryu; Suk Won Seo; Jin Seok Kim; Yousun Chung; Hyungsuk Kim; Sang-Hyun Hwang; Heung-Bum Oh; Won-Ki Min; Dae-Hyun Ko
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

2.  Therapeutic Plasma Exchange as a Treatment for Autoimmune Neurological Disease.

Authors:  Ivana Nieto-Aristizábal; Álvaro J Vivas; Pablo Ruiz-Montaño; Cristian C Aragón; Iván Posso-Osorio; Jairo Quiñones; Julián Alejandro Rivillas; Gabriel J Tobón
Journal:  Autoimmune Dis       Date:  2020-07-31

3.  Clinical characteristics, triggering etiologies, and response of plasmapheresis in thrombotic microangiopathy in Taiwan.

Authors:  Ching-Hu Chung; I-Jung Tsai; Min-Hua Tseng; Hsin-Hsu Chou; You-Lin Tain; Jeng-Daw Tsai; Yuan-Yow Chiou; Yee-Hsuan Chiou; Ching-Yuang Lin
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

4.  Safety and tolerability of solvent/detergent-treated plasma for pediatric patients requiring therapeutic plasma exchange: An open-label, multicenter, postmarketing study.

Authors:  Cassandra D Josephson; Stuart Goldstein; David Askenazi; Claudia S Cohn; Philip C Spinella; Ara Metjian; Ross M Fasano; Lejla Music-Aplenc
Journal:  Transfusion       Date:  2021-12-20       Impact factor: 3.337

Review 5.  Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.

Authors:  Seena Tabibi; Tara Tabibi; Rosalynn R Z Conic; Nassim Banisaeed; Michael B Streiff
Journal:  J Intensive Care Med       Date:  2020-07-15       Impact factor: 3.510

6.  Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.

Authors:  Andri Lemarquis; Tessa Campbell; Maribel Aranda-Guillén; Viktoria Hennings; Petter Brodin; Olle Kämpe; Kaj Blennow; Henrik Zetterberg; Christine Wennerås; Kristina Eriksson; Nils Landegren; Yenan Bryceson; Stefan Berg; Olov Ekwall
Journal:  J Allergy Clin Immunol       Date:  2021-04-16       Impact factor: 10.793

7.  Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS-CoV-2.

Authors:  Yu Cui; Caixia Hu; Yi Cheng; Xiaomei Han; Wenqing Wang
Journal:  Int J Dermatol       Date:  2021-09-14       Impact factor: 3.204

8.  On Therapeutic Plasma Exchange Against Severe COVID-19-Associated Pneumonia: An Observational Clinical Study.

Authors:  Luca Cegolon; Behzad Einollahi; Yunes Panahi; Sina Imanizadeh; Mohammad Rezapour; Mohammad Javanbakht; Mohammad Nikpouraghdam; Hassan Abolghasemi; Giuseppe Mastrangelo
Journal:  Front Nutr       Date:  2022-02-22

Review 9.  TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE.

Authors:  Sven Županić; Ines Lazibat; Maja Rubinić Majdak; Mia Jeličić
Journal:  Acta Clin Croat       Date:  2022-02       Impact factor: 0.932

10.  A Rare Case of HELLP Syndrome with Hematomas of Spleen and Liver, Eclampsia, Severe Hypertension and Prolonged Coagulopathy-A Case Report.

Authors:  Małgorzata Lewandowska; Monika Englert-Golon; Zbigniew Krasiński; Paweł Piotr Jagodziński; Stefan Sajdak
Journal:  Int J Environ Res Public Health       Date:  2022-06-23       Impact factor: 4.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.